Exploring the efficacy and safety of Yu-Ping-Feng powder with variation against allergic rhinitis: a randomized, double-blind, placebo-controlled trial
YPV was well-tolerated and could effectively ameliorate multiple symptoms of AR and improve the quality of life of AR patients after 8-week treatment. Trial registration ClinicalTrials.gov, NCT04976023. Registered 26 July 2021, https://clinicaltrials.gov/study/NCT04976023?cond=The%20Effects%20of%20Using%20Yupingfeng%20Powder%20with%20Variation%20for%20the%20Treatment%20of%20Allergic%20Rhinitis&rank=2.
Authors
- Tin Muk Ho
- Ka Chun Leung (ORCID: https://orcid.org/0000-0001-9250-5476)
- Zhi‐Xiu Lin (ORCID: https://orcid.org/0000-0003-2840-6179)
- Qingqing Xu (ORCID: https://orcid.org/0009-0007-2211-8535)
- Sin Bond Leung
- Justin C. Y. Wu (ORCID: https://orcid.org/0000-0002-2846-9818)
- Tak Yee Chow (ORCID: https://orcid.org/0009-0000-2879-0591)
- Yan‐Fang Xian (ORCID: https://orcid.org/0000-0002-5032-0366)
- Chi Him Sum (ORCID: https://orcid.org/0000-0002-9123-4771)
- Kam‐Lun Ellis Hon (ORCID: https://orcid.org/0000-0002-6682-5529)
- Chon Pin Chia
- Hongwei Zhang (ORCID: https://orcid.org/0000-0002-2288-5394)
- Cho Wing Lo
- Kam Leung Chan
- Wai Ling Lin
- Pui Kuan Cheong
- Jessica Ching
Institutions
- Chinese University of Hong Kong (HK)
Publication Details
- Journal
- Chinese Medicine
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1186/s13020-025-01120-2
- Citations
- 2
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 3.24
Funders
- Chinese University of Hong Kong